These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 21424131

  • 21. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.
    Xu ZY, Loignon M, Han FY, Panasci L, Aloyz R.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498
    [Abstract] [Full Text] [Related]

  • 22. Proteomic analysis of differentiating neuroblastoma cells treated with sub-lethal neurite inhibitory concentrations of diazinon: identification of novel biomarkers of effect.
    Harris W, Sachana M, Flaskos J, Hargreaves AJ.
    Toxicol Appl Pharmacol; 2009 Oct 15; 240(2):159-65. PubMed ID: 19647006
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Association between the unfolded protein response, induced by 2-deoxyglucose, and hypersensitivity to cisplatin: a mechanistic study employing molecular genomics.
    Gaddameedhi S, Chatterjee S.
    J Cancer Res Ther; 2009 Sep 15; 5 Suppl 1():S61-6. PubMed ID: 20009298
    [Abstract] [Full Text] [Related]

  • 27. Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells.
    Hirano G, Izumi H, Kidani A, Yasuniwa Y, Han B, Kusaba H, Akashi K, Kuwano M, Kohno K.
    Mol Cancer Res; 2010 Jun 15; 8(6):864-72. PubMed ID: 20530585
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K, Oshima T, Kobayashi T, Yamamoto N, Hayashi C, Matsumoto T, Miwa H.
    Anticancer Res; 2008 Jun 15; 28(4B):2087-92. PubMed ID: 18751380
    [Abstract] [Full Text] [Related]

  • 30. Comparative proteomic analysis of the esophageal squamous carcinoma cell line EC109 and its multi-drug resistant subline EC109/CDDP.
    Wen J, Zheng B, Hu Y, Zhang X, Yang H, Li Y, Zhang CY, Luo KJ, Zang X, Li YF, Guan XY, Fu JH.
    Int J Oncol; 2010 Jan 15; 36(1):265-74. PubMed ID: 19956855
    [Abstract] [Full Text] [Related]

  • 31. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
    Strathdee G, Davies BR, Vass JK, Siddiqui N, Brown R.
    Carcinogenesis; 2004 May 15; 25(5):693-701. PubMed ID: 14729589
    [Abstract] [Full Text] [Related]

  • 32. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W, Ke S, Chen G, Gao Q, Wu S, Wang S, Zhou J, Yang X, Lu Y, Ma D.
    Oncol Rep; 2004 Dec 15; 12(6):1365-70. PubMed ID: 15547764
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impaired activity of volume-sensitive Cl- channel is involved in cisplatin resistance of cancer cells.
    Lee EL, Shimizu T, Ise T, Numata T, Kohno K, Okada Y.
    J Cell Physiol; 2007 May 15; 211(2):513-21. PubMed ID: 17186499
    [Abstract] [Full Text] [Related]

  • 35. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
    Liu Y, Liu H, Han B, Zhang JT.
    Cancer Res; 2006 Mar 15; 66(6):3248-55. PubMed ID: 16540677
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin.
    Shiota M, Tsunoda T, Song Y, Yokomizo A, Tada Y, Oda Y, Naito S.
    BJU Int; 2011 Apr 15; 107(7):1148-53. PubMed ID: 20726978
    [Abstract] [Full Text] [Related]

  • 38. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 15; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 39. Proteomic characterization of the cytotoxic mechanism of gold (III) porphyrin 1a, a potential anticancer drug.
    Wang Y, He QY, Che CM, Chiu JF.
    Proteomics; 2006 Jan 15; 6(1):131-42. PubMed ID: 16287165
    [Abstract] [Full Text] [Related]

  • 40. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N, Lam YM, Pym J, Campling BG.
    Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.